Quarterly report [Sections 13 or 15(d)]

License Agreement (Details Narrative)

v3.25.3
License Agreement (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
May 31, 2021
May 31, 2020
Sep. 30, 2025
Sep. 30, 2024
Jun. 30, 2025
LicenseAgreementLineItems [Line Items]          
Research and development expense     $ 809,991 $ 1,314,859  
Common stock, par value     $ 0.001   $ 0.001
Vernalis Development Limited [Member]          
LicenseAgreementLineItems [Line Items]          
Research and development expense   $ 150,000      
Vernalis Development Limited [Member] | IPO [Member]          
LicenseAgreementLineItems [Line Items]          
Number of shares of common stock 192,857        
Common stock, par value $ 0.001        
Future milestone payments $ 1,400,000        
Vernalis Development Limited [Member] | Minimum [Member]          
LicenseAgreementLineItems [Line Items]          
Marketing authorization amount   400,000      
Sales milestone payments   10,000,000.0      
Cumulative annual net sales amount   500,000,000.0      
Vernalis Development Limited [Member] | Maximum [Member]          
LicenseAgreementLineItems [Line Items]          
Marketing authorization amount   3,000,000.0      
Development milestone payment   29,900,000      
Sales milestone payments   25,000,000.0      
Cumulative annual net sales amount   $ 1,000,000,000.0